178 related articles for article (PubMed ID: 38306895)
1. High-dimensional profiling of regulatory T cells in psoriasis reveals an impaired skin-trafficking property.
Lee BH; Bang YJ; Lim SH; Kang SJ; Kim SH; Kim-Schulze S; Park CG; Kim HJ; Kim TG
EBioMedicine; 2024 Feb; 100():104985. PubMed ID: 38306895
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of regulatory molecules in the skin of psoriasis.
Sabag AD; Dias-Polak D; Bejar J; Sheffer H; Bergman R; Vadasz Z
Immunol Res; 2018 Dec; 66(6):649-654. PubMed ID: 30613859
[TBL] [Abstract][Full Text] [Related]
3. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3.
Yang L; Li B; Dang E; Jin L; Fan X; Wang G
J Dermatol Sci; 2016 Feb; 81(2):85-92. PubMed ID: 26627723
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset.
Soler DC; Sugiyama H; Young AB; Massari JV; McCormick TS; Cooper KD
Clin Immunol; 2013 Oct; 149(1):111-8. PubMed ID: 23954573
[TBL] [Abstract][Full Text] [Related]
5. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
6. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells.
Goodman WA; Levine AD; Massari JV; Sugiyama H; McCormick TS; Cooper KD
J Immunol; 2009 Sep; 183(5):3170-6. PubMed ID: 19648274
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125a-5p regulates the effect of Tregs on Th1 and Th17 through targeting ETS-1/STAT3 in psoriasis.
Yan K; Zhang F; Ren J; Huang Q; Yawalkar N; Han L
J Transl Med; 2023 Sep; 21(1):678. PubMed ID: 37773129
[TBL] [Abstract][Full Text] [Related]
8. Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis.
Singh K; Gatzka M; Peters T; Borkner L; Hainzl A; Wang H; Sindrilaru A; Scharffetter-Kochanek K
J Immunol; 2013 Mar; 190(6):2544-53. PubMed ID: 23418628
[TBL] [Abstract][Full Text] [Related]
9. Role of CD4CD25FOXP3 Regulatory T Cells in Psoriasis.
Yun WJ; Lee DW; Chang SE; Yoon GS; Huh JR; Won CH; Lee MW; Kim SE; Kim BJ; Moon KC; Choi JH
Ann Dermatol; 2010 Nov; 22(4):397-403. PubMed ID: 21165208
[TBL] [Abstract][Full Text] [Related]
10. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
[TBL] [Abstract][Full Text] [Related]
11. Balance of Treg vs. T-helper cells in the transition from symptomless to lesional psoriatic skin.
Keijsers RR; van der Velden HM; van Erp PE; de Boer-van Huizen RT; Joosten I; Koenen HJ; van de Kerkhof PC
Br J Dermatol; 2013 Jun; 168(6):1294-302. PubMed ID: 23330679
[TBL] [Abstract][Full Text] [Related]
12. A role for CCR5(+)CD4 T cells in cutaneous psoriasis and for CD103(+) CCR4(+) CD8 Teff cells in the associated systemic inflammation.
Sgambelluri F; Diani M; Altomare A; Frigerio E; Drago L; Granucci F; Banfi G; Altomare G; Reali E
J Autoimmun; 2016 Jun; 70():80-90. PubMed ID: 27068801
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of Akt-FOXO1 Pathway Leads to Dysfunction of Regulatory T Cells in Patients with Psoriasis.
Li B; Lei J; Yang L; Gao C; Dang E; Cao T; Xue K; Zhuang Y; Shao S; Zhi D; Hao J; Jin L; Qiao P; Ouyang W; Wang G
J Invest Dermatol; 2019 Oct; 139(10):2098-2107. PubMed ID: 30998985
[TBL] [Abstract][Full Text] [Related]
14. Tailoring the homing capacity of human Tregs for directed migration to sites of Th1-inflammation or intestinal regions.
Hoeppli RE; MacDonald KN; Leclair P; Fung VCW; Mojibian M; Gillies J; Rahavi SMR; Campbell AIM; Gandhi SK; Pesenacker AM; Reid G; Lim CJ; Levings MK
Am J Transplant; 2019 Jan; 19(1):62-76. PubMed ID: 29766641
[TBL] [Abstract][Full Text] [Related]
15. Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4
Chen Y; Zhang Q; Liu H; Lu C; Liang CL; Qiu F; Han L; Dai Z
Front Immunol; 2018; 9():2092. PubMed ID: 30258447
[TBL] [Abstract][Full Text] [Related]
16. IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients.
Shi Y; Chen Z; Zhao Z; Yu Y; Fan H; Xu X; Bu X; Gu J
Front Immunol; 2019; 10():1865. PubMed ID: 31440249
[No Abstract] [Full Text] [Related]
17. Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis.
Rodríguez-Jiménez P; Chicharro P; Llamas-Velasco M; Cibrian D; Trigo-Torres L; Vara A; Jiménez-Fernández M; Sevilla-Montero J; Calzada MJ; Sánchez-Madrid F; de la Fuente H; Daudén E
Front Immunol; 2019; 10():1268. PubMed ID: 31214201
[TBL] [Abstract][Full Text] [Related]
18. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
[TBL] [Abstract][Full Text] [Related]
19. CCR4
Casciano F; Diani M; Altomare A; Granucci F; Secchiero P; Banfi G; Reali E
Front Immunol; 2020; 11():529. PubMed ID: 32318062
[TBL] [Abstract][Full Text] [Related]
20. Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris.
Teraki Y; Miyake A; Takebayashi R; Shiohara T
Clin Exp Dermatol; 2004 Nov; 29(6):658-63. PubMed ID: 15550147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
